Alliancebernstein L.P. raised its position in shares of CME Group Inc. (NASDAQ:CME) by 4.7% in the second quarter, according to its most recent filing with the SEC. The firm owned 624,825 shares of the financial services provider’s stock after purchasing an additional 28,051 shares during the quarter. Alliancebernstein L.P. owned approximately 0.18% of CME Group worth $78,253,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Fiduciary Trust Co. acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $105,000. Parallel Advisors LLC lifted its holdings in shares of CME Group by 4.1% in the 1st quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after purchasing an additional 43 shares in the last quarter. Whittier Trust Co. lifted its holdings in shares of CME Group by 2.6% in the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after purchasing an additional 27 shares in the last quarter. RidgeWorth Capital Management LLC lifted its holdings in shares of CME Group by 55.5% in the 1st quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock worth $135,000 after purchasing an additional 406 shares in the last quarter. Finally, Guardian Life Insurance Co. of America lifted its holdings in shares of CME Group by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock worth $156,000 after purchasing an additional 9 shares in the last quarter. 82.67% of the stock is owned by institutional investors and hedge funds.

Shares of CME Group Inc. (NASDAQ CME) opened at 130.06 on Wednesday. The company has a market capitalization of $44.21 billion, a PE ratio of 26.55 and a beta of 0.72. CME Group Inc. has a 1-year low of $98.95 and a 1-year high of $130.15. The stock’s 50 day moving average price is $125.07 and its 200-day moving average price is $121.81.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. The firm had revenue of $925.00 million for the quarter, compared to the consensus estimate of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 earnings per share. On average, equities analysts predict that CME Group Inc. will post $4.81 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is currently 53.99%.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $124.50, for a total value of $311,250.00. Following the transaction, the chief financial officer now owns 38,495 shares of the company’s stock, valued at $4,792,627.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Chairman Terrence A. Duffy sold 21,815 shares of the stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total value of $2,702,660.35. Following the completion of the transaction, the chairman now directly owns 110,711 shares in the company, valued at approximately $13,715,985.79. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 48,244 shares of company stock worth $6,021,890. Corporate insiders own 0.57% of the company’s stock.

A number of equities analysts recently issued reports on CME shares. Royal Bank Of Canada set a $130.00 target price on CME Group and gave the stock a “buy” rating in a report on Monday, June 12th. UBS AG reiterated a “buy” rating and issued a $134.00 target price (down from $136.00) on shares of CME Group in a report on Monday, June 5th. Citigroup Inc. started coverage on CME Group in a report on Wednesday, July 12th. They issued a “buy” rating and a $140.00 target price on the stock. Jefferies Group LLC reiterated a “buy” rating and issued a $128.00 target price on shares of CME Group in a report on Monday, July 10th. Finally, Deutsche Bank AG cut their target price on CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company’s stock. CME Group currently has an average rating of “Buy” and an average target price of $132.56.

COPYRIGHT VIOLATION WARNING: This report was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2017/09/13/cme-group-inc-cme-holdings-increased-by-alliancebernstein-l-p.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.